Moderna Inc. said its experimental coronavirus vaccine was 94.5% effective at protecting people from Covid-19 in an early look at pivotal study results, the second vaccine to hit a key milestone.

Of 95 people in the study who developed Covid-19 with symptoms so far, 90 had received a placebo and only five Moderna’s vaccine, the company said Monday. The findings move the vaccine closer to wide use, because they indicate it is effective at preventing disease that causes symptoms, including severe cases.

The…

This post first appeared on wsj.com

You May Also Like

Companies Tied to Guo Wengui to Pay $539 Million to Settle SEC Action

WASHINGTON—Three media companies tied to exiled Chinese businessman Guo Wengui have agreed…

Earth makes its closest annual approach to the sun

Here comes the sun. Earth on Tuesday made its closest approach to…

Alex Murdaugh taking the stand was a ‘fatal’ move in murder trial, South Carolina AG says

Alex Murdaugh taking the stand was a “fatal” move for him in…

Ballot language to replace police department gets Minneapolis council’s OK

The Minneapolis City Council on Friday endorsed ballot language that would allow…